The vaccine, which began phase 3 clinical trials in late August, 신림룸사롱 was suspended for a while after side effects were reported in September. A voluntary pause in vaccinations in all global tests for independent monitoring 가락룸사롱 committees to evaluate safety data. However, the results proved to be safe and global clinical trials resumed in late October.
If all three vaccines above are two-time vaccinations, some companies are evaluating single vaccinations. Among the 11 candidate substances currently 강남풀사롱 undergoing three-phase clinical trials, Adenovirus Vector Vaccines, jointly developed by Chinese company Kansino Biologics and Beijing Biotechnology Institute, and Adenovirus Vector Vaccines, jointly developed by Wantai Biopharm, are undergoing 강남텐까페 clinical trials with single inoculations.